Niche Generics Limited
Registered name: NICHE GENERICS LIMITED
Part of Unichem Laboratories Limited groupNiche Generics Limited made £8.1m revenue and a £388k loss in the year to 31 Mar 2025. read from filing text
Niche Generics Limited’s revenue fell 17% to £8.1m in the year to 31 Mar 2025, with a loss of £388k and 53 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Hitchin; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Hitchin, East of England
- Age
- 24 yrs · since 2002
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The Immediate parent company is Unichem Laboratories Limited (a company incorporated in India with registered office address at”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | £8.1m | £7.7m | £9.8m | £8.1m |
| Cost of sales | £3.6m | £3.4m | £3.5m | £3.7m |
| Gross profit | £4.5m | £4.3m | £6.3m | £4.5m |
| Operating profit | −£251k | −£904k | £704k | −£253k |
| Profit before tax | −£415k | −£988k | £556k | −£388k |
| Profit after tax | −£415k | −£988k | £556k | −£388k |
| Profit (best available) | −£415k | −£988k | £556k | −£388k |
| Employees (average) | 55 | 56 | 56 | 53 |
| Ratios | ||||
| Profit margin | −5.1% | −12.8% | 5.7% | −4.8% |
| Gross margin | 55% | 56% | 64.3% | 54.9% |
| Revenue per employee | £147k | £138k | £175k | £153k |
| Profit per employee | −£7.5k | −£17.6k | £9.9k | −£7.3k |
| Cash conversion | — | — | −82.6% | — |
| Growth (year on year) | ||||
| Revenue growth | — | ▼4.6% | ▲27.2% | ▼17.3% |
| Profit growth | — | — | — | ▼169.8% |
| Headcount growth | — | ▲1.8% | 0% | ▼5.4% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £201k | £76.9k | £500k | £340k |
| Net assets | £72.4k | −£916k | −£360k | −£748k |
| Fixed assets | £1.1m | £870k | £621k | £375k |
| Current assets | £4.8m | £4.6m | £5.9m | £5.1m |
| Debtors | £1.7m | £1.7m | £1.8m | £1.2m |
| Deferred income | £270k | £188k | £687k | £238k |
| Cash from operations | −£333k | £6k | −£582k | £23.8k |
| Source | Accounts · bulk data Dec 2023 | Accounts · bulk data Dec 2023 | FullAccounts · bulk data Nov 2024 | FullAccounts · bulk data Nov 2025 |
How the business works
- Profit margin
- −4.8%
- Profit ÷ revenue.
- Gross margin
- 54.9%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £153k
- Revenue ÷ average employees.
- Profit per employee
- −£7.3k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 4.6%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 2.9%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 14.9%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£748k
- Cash at bank
- ▼32%
- Now £340k
- Headcount
- ▼5%
- Now 53
- Deferred income
- ▼65%
- Now £238k
- Fixed assets
- ▼40%
- Now £375k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Unichem Laboratories Limited (registered outside the UK register)ultimate parent75–100%
- Niche Generics Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Ascot Laboratories LimitedBorehamwood · Manufacture of basic pharmaceutical products
- Revenue
- £8.9m
- Profit
- £645k
- Staff
- 66
- New Nordic LimitedLyndhurst · Manufacture of basic pharmaceutical products
- Revenue
- £7.4m
- Profit
- £125k
- Staff
- 5
- Vector Consumer LimitedPrenton · Manufacture of basic pharmaceutical products
- Revenue
- £10.6m
- Profit
- £33.1k
- Staff
- 14
- Pharmapac (U.K.) LimitedBidston, Wirral · Manufacture of basic pharmaceutical products
- Revenue
- £10.8m
- Profit
- £94.7k
- Staff
- 142
- Cosmarida LimitedSheffield · Manufacture of basic pharmaceutical products
- Revenue
- £11.1m
- Profit
- £286k
- Staff
- 90
- Envigo RMS (UK) LimitedLoughborough · Manufacture of basic pharmaceutical products
- Revenue
- £11.4m
- Profit
- £209k
- Staff
- 145
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£388k), from the Companies House accounts bulk data published Nov 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.